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Phase boundary defectnterest in recent years in describing the lateral organization of membranes and
the formation of membrane domains. Much of the focus in this area has been on the formation of cholesterol-
rich domains in mammalian membranes. However, it is likely that there are domains in all biological
membranes. One of the challenges has been to deﬁne the chemical composition, lifetime and size of these
domains. There is evidence that bacteria have domains that are enriched in cardiolipin. In addition, the
formation of lipid domains can be induced in bacteria by clustering negatively charged lipids with
polycationic substances. Many antimicrobial compounds have multiple positive charges. Such polycationic
compounds can sequester anionic lipids to induce lipid phase separation. The molecular interactions among
lipids and their lateral packing density will be different in a domain from its environment. This will lead to
phase boundary defects that will lower the permeability barrier between the cell and its surroundings. The
formation of these clusters of anionic lipids may also alter the stability or composition of existing membrane
domains that may affect bacterial function. Interestingly many antimicrobial agents are polycationic and
therefore likely have some effect in promoting lipid phase segregation between anionic and zwitterionic
lipids. However, this mechanism is expected to be most important for substances with sequential positive
charges contained within a ﬂexible molecule that can adapt to the arrangement of charged groups on the
surface of the bacterial cell. When this mechanism is dominant it can allow the prediction of the bacterial
species that will be most affected by the agent as a consequence of the nature of the lipid composition of the
bacterial membrane.
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There are two general motifs for the organization of bacterial
membranes. These correspond to the membranes of Gram positive
and of Gram negative bacteria. A major difference between these twosaccharide; PE, phosphatidy-
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l rights reserved.classes of bacteria is that Gram positive bacteria have only one
membrane, the cytoplasmic membrane that surrounds the cell, while
Gram negative bacteria have two membranes: the cytoplasmic
membrane and in addition an outer membrane. There are also other
differences. While both Gram positive and Gram negative bacteria
have a peptidoglycan layer on the outer side of the cytoplasmic
membrane, the peptidoglycan layer is much thicker for Gram positive
bacteria and helps to maintain the shape of these bacteria. Another
difference is that both kinds of bacteria contain different lipopoly-
saccharides in their membranes, although both types have in common
that they possess phosphate groups and are negatively charged. In the
case of Gram positive bacteria these lipopolysaccharides are lipotei-
choic acids (LTA) that are imbedded in the cytoplasmic membrane,
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the major lipid component of the outer leaﬂet of the outer membrane.
The outer membrane of Gram negative bacteria is permeable to
hydrophilic molecules smaller than ~600 Da because of the presence
of β-barrel proteins termed porins.
There is a large difference in the lipid composition of bacterial
cytoplasmic membranes. For most bacteria the predominant zwitter-
ionic phospholipid is phosphatidylethanolamine (PE). In general Gram
negative bacteria have a higher content of PE than Gram positive
bacteria. Some Gram positive bacteria have a very low content of
zwitterionic phospholipids. The predominant anionic lipids in
bacterial membranes are phosphatidylglycerol (PG) and cardiolipin
(CL). All bacteria have at least 15% anionic lipid, but this can be either
PG or CL or both and it is not dependent on whether it is a Gram
negative or Gram positive organism. It is the exposure of these anionic
lipids, along with LPS or LTA or peptidoglycan that provide the
selectivity of cationic antimicrobial agents for toxicity against bacteria
but not against mammalian cells.
2. Evidence for domains in bacterial membranes
There is evidence from chemical crosslinking of lipids that the
lateral distribution of lipids is not uniform in bacterial membranes [1].
In the case ofMicrococcus luteus, the amount of homodimers of PG and
of dimannosyldiacylglycerol (DMDG), formed in intact bacteria by
photoactivation of a probe, was higher when compared with PG-
DMDG heterodimers [2]. It was shown that this was not a
consequence of a highly asymmetric transverse distribution of these
lipids, but rather a consequence of the presence of lateral domains.
The distribution of lipids is altered during the cell cycle [3]. In addition
to lipid miscibility, speciﬁc lipids are also involved in the formation of
protein-enriched domains in membranes. An example is the forma-
tion and constriction of FtsZ rings during cell division of Escherichia
coli that is dependent on the presence of PE [4], indicating that PE is
enriched at the septum of a dividing cell.
The presence of domains in E. coli membranes was also shown by
the existence of regions in the membrane with different order and
polarity as measured using the ﬂuorescent probes Laurdan and 1,3-
diphenyl-1,3,5-hexatriene [5]. The existence of domains enriched in
either PE or PG was demonstrated in both E. coli and Bacillus subtilis
using lipids labeled in the sn-2 position with 1-pyrene decanoic acid
[6]. This work showed that PE and PG sequestered into different pre-
existing domains in the bacterial membrane.
There have also been studies showing the presence of membrane
domains in bacteria using ﬂuorescence microscopy imaging methods.
The selective staining of septal regions has been observed in
mycobacteria [7] and the uneven distribution of a lipophilic dye in E.
coli has been used to demonstrate membrane domain formation [8]. It
has been suggested that lipid domains may be important for certain
regulatory functions of the cell [1,9,10]. In particular, domains of acidic
lipids may be important for the initiation of chromosome replication
in E. coli [11,12].
Formation of domains enriched in CL has attracted particular
attention, in part because there is evidence that 10-nonyl acridine
orange (NAO) is a cardiolipin-speciﬁc dye [13] that can be used for
imaging. It has been shown that CL localizes at the polar and septalFig.1. Cartoon illustrating the type of lipid rearrangement that can occur on binding certain ca
domain occurs as a consequence of binding to the antimicrobial agent. This causes a rearra
anionic lipids from other locations in the membrane where they may be required for functiregions of the cytoplasmic membrane of E. coli [14,15] as well as in B.
subtilis [16]. In addition, elevated levels of CL were found in the
membrane of E. coliminicells that are derived from the cell poles [17].
The polar and septal targeting of CL has also been suggested to have a
direct role in the targeting of an osmosensory transporter, ProP [18,19].
A recent paper using continuum mean-ﬁeld analysis of membrane
energetics suggests that there is a critical concentration of CL required
for microphase separation [20]. This study also suggests that there is a
relationship between CL domain formation and membrane curvature.
Mukhopadhyay et al. [20] predict that spherical bacteria will not
exhibit large-scale CL localization without variations in cell wall
curvature. Curvature also explains why CL localizes to the higher
curvature division sites in E. coli [14,15] and B. subtilis [16]. Another
membrane lipid with high negative curvature tendency, PE, is also
found in these high curvature regions at the poles of E. coli and B.
subtilis [4,21].
3. Promotion of domain formation by antimicrobial compounds
Antimicrobial agents have a wide variety of chemical structures
[22]. Several mechanisms have been proposed to account for their
protection against infection including effects on the innate immune
system [23], damage to the cytoplasmic membrane of bacteria [24],
binding to DNA [25] or inhibition of speciﬁc bacterial metabolic
processes [26]. These agents do not have a high speciﬁcity. Many are
selectively toxic to bacteria because these organisms, unlike
mammalian cells, contain exposed anionic groups. Even nisin, an
antibiotic with a high degree of speciﬁcity of binding to lipid II, has
recently been shown to have several modes of action [27]. Hence in
many cases there is likely more than one factor contributing to the
toxicity of antimicrobial agents. The membrane plays an important
role in many of the mechanisms of toxicity of these agents either as
a target of the antimicrobial compound, resulting in damage to the
membrane or as a barrier that must be traversed by the toxic agent
to gain access to an intracellular target. Mechanisms of membrane
damage have generally focused on how an antimicrobial cationic
agent can disrupt membrane bilayer organization by forming pores
lined by both lipids and peptides [28] or by a more general “carpet
mechanism” [24].
Recently, a more speciﬁc mechanism has been suggested for
breaching the permeability barrier of membranes that involves the
antimicrobial cationic agent inducing separation of lipid components,
resulting in the clustering of anionic lipids (see Fig. 1) and possibly the
formation of phase boundary defects between lipid domains [29–31].
Phase boundary defects have been suggested to be responsible for the
increased leakage of liposomes at the phase transition temperature
where gel and liquid crystalline domains coexist [32]. However,
segregated phases or domains in membranes do not by themselves
lead to toxicity, since it is believed that domains are commonly
present in biological membranes. We suggest that because of the large
molecular heterogeneity in biological membranes domain interfaces
are stabilized by concentrating other molecules at the domain
interface to lower the membrane tension. In contrast, when domains
are acutely formed as a consequence of the addition of an
antimicrobial agent, there is insufﬁcient time for the membrane to
rearrange to accommodate this change in organization. Such ationic antimicrobial agents. Clustering of anionic lipids (red headgroups) into a separate
ngement of lipids around the domain, leaving defects in the membrane and recruiting
on.
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pounds that have a sequence rich in cationic residues and have
conformational ﬂexibility that can adapt to the distance between
charges on the membrane surface. In addition to the increased
permeability caused by the formation of phase boundary defects, the
membrane lipid rearrangements caused by the clustering of anionic
lipids are also likely to perturb existing domains in the membrane,
adversely affecting the bacteria. The importance of induced lateral
phase separation has been speciﬁcally proposed as a mechanism
contributing to the antimicrobial activity of a designed alpha/beta-
peptide [29], for a ﬂexible sequence-random polymer [30], for
cateslytin [31] and for an oligo-acyl-lysine (OAK) [33].
This group of four antimicrobial agents represents diverse
chemical structures and conformational motifs. They are not likely
to be the only compounds for which lipid segregation plays a role in
the mechanism of antimicrobial action. Furthermore, clustering of
anionic lipids is not likely to be the sole mechanism by which these
agents act to kill bacteria, but rather it is an additional contributory
factor, more important for some antimicrobial agents than for
others. For example, we have also shown that the ﬂexible sequence-
random polymer can kill bacteria by encapsulating them, indepen-
dent of any damage to the cytoplasmic membrane [30]. Factors that
would facilitate preferential interaction with anionic lipids and the
promotion of phase segregation are:
1. The presence of multiple cationic groups allowing one molecule of
the antimicrobial agent to interact with several anionic lipid
molecules.
2. A conformational ﬂexibility to facilitate the adoption of a
conformation in which the distance between positive charges
matched the distance between anionic lipids in the bacterial
membrane after clustering.
3. Being sufﬁciently hydrophobic to spontaneously partition to a
membrane.Fig. 2. (A) Structures of α/β-peptides I and II. (B) Schematic views of α/β-peptides I and II i
analogous to “helical wheel” diagrams for α-peptides). These perspectives show that when th
from [35].Two alpha/beta peptides have been synthesized having identical
chemical composition but differing in the distribution of cationic
groups [34]. Both of these peptides are believed to form a “14/15-
helical conformation” [34]. One of these peptides, referred to as α/β-
peptide I, has the cationic groups regularly distributed on the
sequence so that it folds into a structure in which these groups are
clustered along the length of one face of the 14/15-helix (Fig. 2). The
other analog, α/β-peptide II, has the cationic residues more clustered
in the primary structure so that the charges are distributed around the
long axis of the helix. It is found by studying ﬂuorescence resonance
energy transfer between labeled lipids that α/β-peptide II is more
effective in segregating anionic and cationic lipids than is α/β-peptide
I [29]. This is in accord with the ﬁnding that α/β-peptide II is more
toxic to E. coli [34]. Because α/β-peptide II has a less rigid structure
when bound to membranes its cationic groups can adapt to the
distance between negative charges on membrane lipids. The amphi-
pathic helical α/β-peptide I would have more ﬁxed distance between
charges in the helical structure and therefore less adaptable to the
membrane. Nevertheless, α/β-peptide I is equally potent to α/β-
peptide II against B. subtilis. Presumably this toxicity of α/β-peptide I
against B. subtilis is by a mechanism different from phase separation.
Like for other cationic amphipathic α-helical antimicrobial peptides,
such as magainin, the mechanism may be pore formation induced by
the peptide.
The sequence-random polymers containing cationic and lipophilic
subunits (Fig. 3) also possess properties that would allow them to
sequester anionic lipid. They were designed and shown to be random
structures in solution, but are suggested to cluster positive charges at
an anionic membrane interface (Fig. 4) [35]. It was shown by
differential scanning calorimetry (DSC) that one of these sequence-
random cationic copolymers can sequester anionic lipids [30].
Cateslytin is a 15 amino acid peptide with 5 cationic residues in the
form of Arg. The sequence of cateslytin is RSMRLSFRARGYGFR. The
positive charges are not placed at regular intervals along the sequence,
suggesting that the peptide will not form amphipathic structures,n idealized 14/15-helical conformations, viewed along the helix axis (these images are
e α/β-peptides are helical, I is expected to be globally amphiphilic while II is not. Taken
Fig. 3. We show the generic structure of these sequence-random copolymers. The
version used in our studies has an average length of 21 subunits and an average
molecular weight of 2800 (Mn/Mw=1.4) as well as m:n=2:3 (it is referred to as 360 in
[27]).
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unstructured in solution but forms aggregates containing antiparallel
β-structure on an anionicmembrane surface [31]. The Arg residues are
involved in the binding of this peptide to anionic membrane surfaces
[31]. Because the charges on the peptide are not spaced at alternate
residues, we suggest that the β-structure formed on the membrane
surface must have sufﬁcient conformational ﬂexibility to allow the
guanidine groups of Arg to position themselves so as to interact with
the negative charges of the membrane surface. It has been shown by
2H NMR that this results in the formation of zones on the membrane
with different rigidity and thickness [31]. This work also showed that
the peptide did not cause destruction of the membrane and it was
suggested that the presence of phase boundary defects allowed for
increased membrane permeability [31].
OAKs are linear sequences of alternating acyl chains and cationic
Lys residues (see Fig. 5) [36–39]. OAKs are rich in positive charge andFig. 4. Complementary hypotheses that can explain the antibacterial activity of host-defen
peptides. (A) The standard hypothesis for peptides such as magainins or cecropins involves in
membrane. The globally amphiphilic conformation is proposed to be responsible for disruptio
regular conformations, have been invoked to explain the activity of many unnatural antibac
here for random copolymers, involves induction of globally amphiphilic but irregular confobecause of the presence of the acyl groups, they are relatively
hydrophobic and can partition well into membranes. These com-
pounds do not form ordered secondary structures and are therefore
capable of adapting their conformation to bind to anionic groups on a
membrane surface and to induce lateral phase separation. We have
shown both by DSC and by 31P MAS/NMR that one of these OAKs, the
octamer C12K-7α8, is capable of interacting with anionic lipids and of
segregating anionic and zwitterionic lipids [33].
4. Relationship of bacterial membrane lipid composition and the
potency of certain antimicrobial agents
Bacteria vary widely in the lipid composition of their membranes
and would therefore be expected to exhibit different sensitivities to
antimicrobial compounds that act at the cell surface. With regard to
agents that act by inducing lateral phase separation, onewould expect
that bacteria whose membranes are composed predominantly of
anionic lipids would be more resistant to these antimicrobial agents
since they would have insufﬁcient zwitterionic phospholipids to form
separate domains. However, these differences among bacterial species
are relative and not absolute. The induction of lateral phase separation
causing defects in membranes is just one of many mechanisms of
action of antimicrobial agents. Thus, it is usually found that even
bacteria that lack zwitterionic lipids are killed by agents that induce
lateral phase separation, but probably by another mechanism.
Generally PG, CL and PE account for a very large fraction of the
phospholipids of bacterial membranes. However, other lipids are
signiﬁcant components of some bacteria. Such lipids can include
glycolipids, lysyl-phosphatidylcholine and lysyl-cardiolipin. Wese peptides and synthetic oligomers and polymers that are designed to mimic these
duction of a globally amphiphilic helix folding pattern upon interactionwith a bacterial
n of the bacterial membrane. Variations on this hypothesis, all involving the induction of
terial oligomers. (B) An alternative hypothesis, which can explain the activity reported
rmations in the presence of a bacterial membrane (taken from [27]).
Table 1
Antimicrobial activity of human catestatin
Bacterial Species % Total lipid MIC (μM)
CL PG PE DMDGa
Gram negative bacteria
P. aeruginosa 8 3 60 – 6.2
E. coli 5 15 80 – 15
Gram positive bacteria
M. luteus 5 60 – 30 5
Streptococcus (Group A) 50 50 – – 75
S. aureus 42 58 – – N100
a DMDG is dimannosyldiacylglycerol.
Table 2
Lipid composition and MIC of C12K-7α8 against various bacteria
Bacterial species % Total lipid MIC (μM) Reference
CL PG PE
Gram negative bacteria
E. coli – 15 80 1.6–3.1 [39]
E. cloacae 3 21 74 1.6 [39]
Y. kristensenii 20 20 60 1.6 [39]
P. mirabilis 5 10 80 6.2 [39]
K. pneumoniae 6 5 82 3.1 [39]
P. aeruginosa 11 21 60 6.2 [39]
Gram positive bacteria
Staphylococcus aureus 42 58 0 50 [39]
Streptococcus pneumonia 50 50 0 50 [33]
Bacillus cereus 17 40 43 12 [37,39]
Bacillus polymyxa 8 3 60 6.2 [33]
Fig. 5. Chemical structure of a typical OAK. Brackets deﬁne α8 (aminooctanoyllysyl)
subunits where n=7 in the OAK, C12K-7α8, used to study phase segregation.
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activity against Enterococcus faecium. This species contains 20% of the
cationic lipid, lysyl-phosphatidylglycerol. This could both facilitate
antimicrobial action by promoting phase segregation induced by a
cationic antimicrobial agent, as well as inhibiting this action as a
consequence of disfavouring sequestering these cationic agents to a
more positively charged bacterial cell surface. There is also the
presence of an outer membrane of Gram negative bacteria that can
affect resistance, as well as the changes in the acyl chain composition
and/or changes in lipid composition during the cell cycle. In addition,
there is some limitation in the amount of information about bacterial
membrane lipid compositions available in the literature. With some
exceptions, many of the lipid analyses of bacterial membranes were
performed using methodologies that are not as quantitative or
comprehensive as those available today. In addition, the agents we
have discussed are relatively new and in some cases there is not a
great deal of literature available in which antimicrobial action was
tested against a broad range of bacteria. Nevertheless, despite these
limitations, we can demonstrate a strong correlation between the lipid
composition of bacteria and the ability of antimicrobial agents to
induce lateral phase separation.
In the case of α/β-peptide II, the minimal inhibitory concentra-
tion (MIC) against E. coli and against B. subtilis are both 6.3 μg/mL
[34]. These bacterial species contain both anionic and zwitterionic
lipids with 80 and 12%, respectively, of the zwitterionic phospholi-
pid, PE. The α/β-peptide II can therefore segregate domains enriched
in anionic or in zwitterionic lipid in these species. In contrast, Sta-
phylococcus aureus has very little zwitterionic lipid and therefore
should be resistant to α/β-peptide II because there are no other
lipids for anionic ones to segregate from. In agreement with this, α/
β-peptide II does have a higher MIC of 12.5 μg/mL against S. aureus
[34], but the difference among these MICs is small and suggests that
other mechanisms contribute to the antimicrobial action. However,
the comparison between α/β-peptide II and its analog α/β-peptide I
is consistent with the suggestion that with α/β-peptide II the
additional mechanism is inducing lateral phase separation. The α/β-
peptide I does not induce domain formation [29]. E. coli membranes
contain both anionic and zwitterionic lipids and should thus be
sensitive to agents that induce lateral phase separation. In agree-
ment with the ﬁnding that α/β-peptide I does not induce phase
separation while α/β-peptide II does, the MIC of α/β-peptide I
against E. coli is 100 μg/mL, much greater that that for α/β-peptide II
that is 6.3 μg/mL, indicating that the induction of lateral phase
separation contributes to its toxicity.
In the case of the random cationic copolymer, the MIC against S.
aureus that is devoid of zwitterionic lipid, is almost 10-fold higher
than against B. subtilis that has 12% of the zwitterionic PE [35], And
with the Gram negative bacteria, E. coli, it has a MIC that is two fold
lower than that for S. aureus [35].
The MICs for cateslytin against various species of bacteria have
been determined [40,41] and are summarized in Table 1, together with
the lipid compositions of these bacteria. There are two groups of
bacteria. One group comprising Pseudomonas aeruginosa, E. coli and
M. luteus have MICs in the range 5–15 μM. All three of these bacterialspecies have membranes with both uncharged and anionic lipids that
can phase-segregate. In the case of M. luteus, DMDG is an uncharged
lipid. Bacteria largely devoid of uncharged lipids, Streptococcus and S.
aureus, have much higher MICs, in the range of 75 to N100 μM. This
would be consistent with the hypothesis that catestatin acts by
clustering anionic lipids and forming phase boundary defects [31] and
can do this only with bacteria that have substantial amounts of both
cationic and uncharged lipid.
The antimicrobial activity of the OAK, C12K-7α8, has been tested
againstmany bacterial species (Table 2). One of the unusual features of
the microbial speciﬁcity of this OAK is that it is generally more toxic to
Gram negative bacteria than Gram positive ones. More commonly
Gram negative bacteria are more resistant to antimicrobial agents
because they have an additional protective barrier of the outer
membrane. The outer membrane may also function to bind to a
cationic antimicrobial agent and prevent its access to the cytoplasmic
membrane. We believe Gram negative bacteria are more easily killed
with OAKs because their membranes have a high concentration of the
zwitterionic lipid PE together with anionic lipids. The OAK can
therefore induce phase separation by preferentially interacting with
and clustering the anionic lipid component. This is supported by the
ﬁnding that two Gram positive bacteria, Bacillus cereus and Bacillus
polymyxa, that have a high content of PE, also have a MIC that is
considerably lower than it is for the two Gram positive bacteria whose
membrane lipids are largely anionic (Table 2). An additional example is
the Gram positive bacterial species Listeria seeligeri that has a MIC of
6.2 μM[39]. Twopredominant lipids in this organismare cardiolipin and
lysyl-cardiolipin [42]. Since lysyl-cardiolipin has equal numbers of
positive and negative changes, L. seeligeri, is another example of a Gram
positive bacteria that can form domains with anionic and uncharged
lipids. Hence the MIC of L. seeligeri is much lower than that for bacteria
whose membranes are composed largely of anionic lipids (Table 2).
The fact that the lipid composition of the bacteria will provide a
predictable feature contributing to the sensitivity of the bacteria to
certain antimicrobial agents can be used to design new drugs with a
more limited range of bacterial toxicities. The mechanism of inducing
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negative bacteria than for Gram positive species since most Gram
negative bacteria have signiﬁcant amounts of both anionic and
zwitterionic lipids. This may be an important feature in designing
antimicrobial therapies, given that Gram negative bacteria are
generally more resistant to antimicrobial agents.
5. Summary and conclusions
The chemical nature of antimicrobial agents is quite diverse. One
would therefore not anticipate that they would all function by similar
mechanisms. In this review we have focused on examples of
antimicrobial agents that promote the formation of domains in
membranes. These substances have multiple cationic charges arrayed
in a ﬂexible structure. In the examples we have chosen, the particular
properties of the molecules endow them with an ability to segregate
membrane domains. This combination of properties is somewhat
speciﬁc since related analogs such as α/β-peptide I or the OAK, C12K-
5α8, are much more weakly potent in inducing domain formation.
Although this mechanism of domain formation is more important for
some antimicrobial agents than for others, it likely contributes to
some extent to the toxicity of many antimicrobial agents, most of
which have many positive charges. Compounds that promote
clustering of anionic lipids in model membranes are found to be
selectively toxic to bacteria with both anionic and uncharged lipids in
their membranes, indicating that a major contributing factor to the
antimicrobial action of these agents is their ability to segregate lipids
into domains. This can result in a lowering of the membrane
permeability barrier as a consequence of the formation of packing
irregularities at the locations where the two phases become
juxtaposed. An attractive feature of this mechanism is that it can be
used to rationally design antimicrobial agents with toxicity selective
for certain organisms.References
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